HBIO Stock Price, Chart, Stats & News

Harvard Bioscience, Inc.
Save
27.31M
Market cap
–
Current P/E
15.06x
Forward P/E
HBIO chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 53.01% |
Operating margin | -0.73% |
Pretax margin | -66.30% |
Net margin | -65.51% |
Effective tax rate | 1.20% |
ROA | -70.81% |
ROE | -388.56% |
D/E | 3.22x |
Interest coverage ratio | -0.13x |
HBIO valuation
P/E | – |
P/S | 0.25x |
P/B | 1.57x |
P/CF | 3.34x |
P/FCF | 4.29x |
P/OCF | 3.34x |
PEG | 0.07x |
EV multiple | -2.61x |
About
Harvard Bioscience, Inc. (HBIO) is a global provider of cutting-edge technologies, products, and services crucial for fundamental scientific investigation, drug discovery, and preclinical testing. Serving both domestic and international markets, the company supplies an extensive range of cellular and molecular instruments. This includes precision fluid handling devices like syringe and peristaltic pumps, alongside a variety of tools and accessories for tissue and organ-based laboratory research, such as surgical instruments, infusion systems, and behavioral analysis setups.
Similar securities
Based on sector and market capitalization
Report issue











